Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoma | 3 | 2023 | 147 | 0.960 |
Why?
|
| Sarcoma, Synovial | 1 | 2022 | 12 | 0.770 |
Why?
|
| Platelet-Rich Plasma | 1 | 2019 | 87 | 0.560 |
Why?
|
| Retrospective Studies | 6 | 2023 | 3538 | 0.210 |
Why?
|
| Postoperative Complications | 3 | 2018 | 916 | 0.210 |
Why?
|
| Neutrophils | 1 | 2023 | 104 | 0.200 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2022 | 810 | 0.200 |
Why?
|
| Margins of Excision | 1 | 2022 | 32 | 0.190 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 93 | 0.170 |
Why?
|
| Time Factors | 2 | 2022 | 1433 | 0.170 |
Why?
|
| Inpatients | 2 | 2018 | 125 | 0.170 |
Why?
|
| Platelet Count | 1 | 2019 | 16 | 0.160 |
Why?
|
| Databases, Factual | 2 | 2017 | 347 | 0.160 |
Why?
|
| Collagen Type II | 1 | 2019 | 22 | 0.160 |
Why?
|
| Chondrogenesis | 1 | 2019 | 30 | 0.150 |
Why?
|
| Proteoglycans | 1 | 2019 | 140 | 0.150 |
Why?
|
| Cell Differentiation | 1 | 2019 | 137 | 0.150 |
Why?
|
| Length of Stay | 2 | 2017 | 313 | 0.150 |
Why?
|
| Cell Proliferation | 1 | 2019 | 175 | 0.150 |
Why?
|
| Outpatients | 1 | 2018 | 61 | 0.150 |
Why?
|
| Humans | 9 | 2023 | 27075 | 0.140 |
Why?
|
| Chondrocytes | 1 | 2019 | 150 | 0.140 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 47 | 0.140 |
Why?
|
| Data Collection | 1 | 2017 | 91 | 0.140 |
Why?
|
| Spondylosis | 1 | 2017 | 27 | 0.140 |
Why?
|
| Spine | 1 | 2017 | 108 | 0.130 |
Why?
|
| Hip Prosthesis | 1 | 2022 | 539 | 0.130 |
Why?
|
| Hospital Costs | 1 | 2017 | 59 | 0.130 |
Why?
|
| Spinal Diseases | 1 | 2017 | 110 | 0.130 |
Why?
|
| Adult | 4 | 2022 | 7831 | 0.130 |
Why?
|
| Low Back Pain | 1 | 2017 | 130 | 0.120 |
Why?
|
| Osteoarthritis | 1 | 2019 | 330 | 0.110 |
Why?
|
| Orthopedic Procedures | 1 | 2017 | 309 | 0.110 |
Why?
|
| Range of Motion, Articular | 1 | 2017 | 708 | 0.110 |
Why?
|
| Lumbar Vertebrae | 1 | 2017 | 383 | 0.100 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2018 | 637 | 0.090 |
Why?
|
| Spinal Fusion | 1 | 2017 | 457 | 0.080 |
Why?
|
| Prognosis | 2 | 2023 | 785 | 0.080 |
Why?
|
| Hospitals | 2 | 2018 | 167 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 329 | 0.060 |
Why?
|
| Reoperation | 2 | 2022 | 925 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2022 | 3485 | 0.060 |
Why?
|
| Middle Aged | 4 | 2021 | 8923 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2023 | 1779 | 0.060 |
Why?
|
| Risk Factors | 2 | 2022 | 2302 | 0.050 |
Why?
|
| Lymphocyte Count | 1 | 2023 | 17 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 20 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2023 | 58 | 0.050 |
Why?
|
| Young Adult | 2 | 2021 | 1994 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2018 | 1890 | 0.050 |
Why?
|
| Female | 4 | 2021 | 15213 | 0.050 |
Why?
|
| SEER Program | 1 | 2021 | 42 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 347 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 4777 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2022 | 490 | 0.040 |
Why?
|
| Infant | 1 | 2021 | 564 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2021 | 641 | 0.040 |
Why?
|
| Femur | 1 | 2022 | 378 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2021 | 642 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2018 | 39 | 0.040 |
Why?
|
| Prosthesis Failure | 1 | 2022 | 523 | 0.040 |
Why?
|
| Data Accuracy | 1 | 2017 | 4 | 0.040 |
Why?
|
| Data Mining | 1 | 2017 | 5 | 0.040 |
Why?
|
| Male | 3 | 2021 | 14772 | 0.040 |
Why?
|
| Operative Time | 1 | 2017 | 91 | 0.030 |
Why?
|
| Surgeons | 1 | 2018 | 87 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 270 | 0.030 |
Why?
|
| Child | 1 | 2021 | 1295 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 395 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 474 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 481 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 8997 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 255 | 0.030 |
Why?
|
| Chicago | 1 | 2018 | 949 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2017 | 624 | 0.030 |
Why?
|
| Adolescent | 1 | 2021 | 2172 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 644 | 0.030 |
Why?
|
| United States | 1 | 2017 | 2035 | 0.020 |
Why?
|